Print Program
FRIDAY, SEPTEMBER 15, 2017 | |
08:30-10:00 | Session 1: The oocyte I Chairs: Milton Leong, Hong Kong & Zeev Shoham, Israel |
08:30 | Welcome Zeev Shoham, Israel, Milton Leong, Hong Kong |
08:30-09:00 | Oocyte quality: Dysmorphic patterns and cytoskeletal alterations in human oocytes Giovanni Coticchio, Italy |
09:00-09:30 | Making human oocytes from stem cells Evelyn Telfer, UK |
09:30-10:00 | Identification of maturation-specific proteins in human oocytes by single-cell proteomics Irma Virant-Klun, Slovenia |
10:00-10:30 | Coffee Break & Poster Viewing |
10:30-11:30 | Session 2: AMH for what? Chairs: David Albertini, USA & Norbert Gleicher, USA |
10:30-11:00 | New bio markers of ovarian reserve: AMH or nucleic acids - what is the best? Samir Hamamah, France |
11:00-11:30 | Administration of Anti-Mullerian Hormone (AMH) to prevent loss of ovarian reserve and protect fertility in chemotherapy treated mice Dror Meirow, Israel |
11:30-13:00 | Session 3: Special lectures: New developments Chairs: David Albertini, USA & Norbert Gleicher, USA |
11:30-12:00 | ART’S brave new world: The cat’s out of the bag… Newest unexpected discoveries in fundamental molecular, cell and reproductive biology Gerald Schatten, USA |
12:00-12:30 | Recent advances in endometrial receptivity diagnosis Xavier Santamaria Costa, Spain |
12:30-12:45 | In vitro formation of follicle-like structures from aggregations of human ovarian cells sorted using the external epitope of DDX4 Marie McLaughlin*; Yvonne Clarkson; Lori McPartlin; Yvonne White; Richard Anderson; Evelyn Telfer, UK |
12:45-13:00 | Co-transplantation of human ovarian tissue with IGF-1 producing endothelial cells improves survival of early stage follicles and is associated with accelerated follicular growth in vivo Limor Man*; Jovana Lekovich; Laura Park; Richard Bodine; Nikica Zaninovic; Zev Rosenwaks; Glenn Schattman; James Daylon, USA |
13:00-13:45 | Lunch Break & Poster Viewing |
13:45-15:15 | Session 4: Ovarian reserve and aging Chairs: Kenneth S. Korach, USA & Herman Tournaye, Belgium |
13:45-14:15 | Can we stop ovarian ageing? Helen Picton, UK |
14:15-14:45 | Establishment of the ovarian reserve: New insights from basic science and their clinical implications Humphrey Yao, USA |
14:45-15:15 | Revisiting the ovarian stroma: More than a holding zone for the follicle David Albertini, USA |
15:15-15:45 | Coffee Break & Poster Viewing |
15:45-17:45 | Session 5: Egg & embryo health Chairs: Helen Picton, UK & Ariel Weissman, Israel |
15:45-16:15 | How small differences in dissolved oxygen in follicular fluid influence the developmental competence of the mature human oocyte at the molecular and plasmalemmal levels: Lessons from IVM, IVF and ICSI Jonathan Van Blerkom, USA |
16:15-16:45 | Nothing more controversial than PGS Norbert Gleicher, USA |
16:45-17:15 | Differences in chromosome abnormalities in eggs and embryos between fertility centers Santiago Munne, USA |
17:15-17:45 | Maximizing successful implantation: TLI, PGS and AnxaV M2 haplotype Simon Fishel, UK |
17:45 | Welcome Reception |
SATURDAY, SEPTEMBER 16, 2017 | |
08:30-10:25 | Session 6: Implantation Chairs: Pedro Barri, Spain & Anna Veiga, Spain |
08:30-08:55 | How to make the best use of the natural cycle for frozen-thawed embryo transfer Ariel Weissman, Israel |
08:55-09:20 | Direct correlation between the serum Beta hCG level prior to egg retrieval and blastocyst formation. How come we have all missed it? Matan Yemini, USA |
09:20-09:45 | Searching for the optimal vehicle and dose of progesterone to support the luteal phase in ART Herman Tournaye, Belgium |
09:45-10:10 | Mini hCG for luteal phase support - a more physiologic LPS for ART treatment Robert Fischer, Germany |
10:10-10:25 | The relationship between blastocyst inner cell mass size and pregnancy outcome Sheila Fieldust, Israel |
10:25-11:00 | Coffee Break |
11:00-12:00 | Session 7: Embryonic health Chairs: Robert Fischer, Germany & Evelyn Telfer, UK |
11:00-11:30 | In vitro culture in the presence of amorphous calcium carbonate improves mouse embryo compaction and hatching rates Amir Arav, Israel |
11:30-12:00 | Epigenetics effects from exposure toxicity of embryo’s Kenneth S. Korach, USA |
12:00-13:00 | Session 8: Rejuvenating the oocyte Chair: Helen Picton, UK |
12:00-12:30 | Mitochondria replacement strategies – When is it justified, and when NOT Peter Braude, UK |
12:30-13:00 | The strict regulation of the mitochondrial genome during development Justin St. John, Australia |
13:00-14:00 | Lunch Break |
14:00-16:00 | Session 9: Stimulation and ovulation Chairs: David Albertini, USA & Neeta Singh, India |
14:00-14:30 | Ovarian stimulation and inflammation, not always friends! Marc-André Sirard, Canada |
14:30-15:00 | Adjuvant rLH to rFSH therapy in GnRH analogue cycles: What do recent meta-analyses add to current understanding? Johnny S. Younis, Israel |
15:00-15:30 | The place for surgical treatment for PCOS Gab Kovacs, Australia |
15:30-16:00 | The prostaglandin transporter (PGT): A novel indispensable mediator of ovulation - from basic research to clinical implications Ariel Hourvitz, Israel |
16:00-16:15 | Coffee Break |
16:15-18:00 | Session 10: IVM: Innovations in this field Chairs: Gerald Schatten, USA & Zeev Shoham, Israel |
16:15-16:45 | In vitro systems to support complete development of immature oocytes Evelyn Telfer, UK |
16:45-17:15 | Protein source in embryo culture media affects DNA methylation and gene expression at the blastocyst Pilar Coy, Spain |
17:15 | Closing remarks |
Please Note!
Any educational grants provided by our supporters are unrestricted.